| 1 |
Establishment of a liver fibrosis model in cynomolgus monkeys |
|
|
| Ke Ding,Man-Rong Liu,Jianmin Li,Ke Huang,Yi Liang,Xiaobin Shang,Jiong Chen,Jian Mu,Huimei Liu |
|
| Experimental and Toxicologic Pathology. 2014; 66(5-6): 257 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 2 |
Effect of antioxidant therapy on hepatic fibrosis and liver iron concentrations in β-thalassemia major patients |
|
|
| Elalfy, M.S. and Adly, A.A.M. and Attia, A.A.M. and Ibrahim, F.A. and Mohammed, A.S. and Sayed, A.M. |
|
| Hemoglobin. 2013; 37(3): 257-276 |
|
| [Pubmed] [Google Scholar] |
|
| 3 |
Inhibition of hepatic fibrosis with artificial microRNA using ultrasound and cationic liposome-bearing microbubbles |
|
|
| D Yang,Y-H Gao,K-B Tan,Z-X Zuo,W-X Yang,X Hua,P-J Li,Y Zhang,G Wang |
|
| Gene Therapy. 2013; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 4 |
Effect of Antioxidant Therapy on Hepatic Fibrosis and Liver Iron Concentrations in ß-Thalassemia Major Patients |
|
|
| Mohsen S. Elalfy,Amira A.M. Adly,Atef A.M. Attia,Fatma A. Ibrahim,Amer S. Mohammed,Abdelbasset M. Sayed |
|
| Hemoglobin. 2013; 37(3): 257 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 5 |
Cellular mechanisms of tissue fibrosis. 1. Common and organ-specific mechanisms associated with tissue fibrosis |
|
|
| Zeisberg, M. and Kalluri, R. |
|
| American Journal of Physiology - Cell Physiology. 2013; 304(3): C216-C225 |
|
| [Pubmed] [Google Scholar] |
|
| 6 |
Prospective non-invasive follow-up of liver fibrosis in patients with chronic hepatitis C |
|
|
| Crisan, D. and Radu, C. and Grigorescu, M.D. and Lupsor, M. and Feier, D. and Grigorescu, M. |
|
| Journal of Gastrointestinal and Liver Diseases. 2012; 21(4): 375-382 |
|
| [Pubmed] [Google Scholar] |
|
| 7 |
Antifibrotic potential of a selective COX-2 inhibitor (celecoxib) on liver fibrosis in rats |
|
|
| Mona M. Ftahy, Noha S. Abdl Latif, Essam F. Alalkamy, Fatma A. El-Batrawi, Ahmad H. Galal, Hany M. Khatab |
|
| Comparative Clinical Pathology. 2012; |
|
| [HTML Full text] [Google Scholar] [DOI] |
|
| 8 |
KangXian FuFang I inhibits acetaldehyde-stimulated extracellular matrix synthesis and cytokine secretion in cultured hepatic stellate cells |
|
|
| Lin, H., Huang, Y.-H., Li, Y.-L., Fu, B.-Y., Wang, B.-Y. |
|
| World Chinese Journal of Digestology. 2011; 19(17): 1826-1829 |
|
| [Pubmed] [Google Scholar] |
|
| 9 |
Pharmacological therapy of nonalcoholic steatohepatitis |
|
|
| Hojo, M. and Watanabe, S. |
|
| Hepatology Research. 2011; 41(3): 209-216 |
|
| [Pubmed] [Google Scholar] |
|
| 10 |
Induction of heme oxygenase-1 protects against nutritional fibrosing steatohepatitis in mice |
|
|
| Rong Wang,Yue Nan,Wen Wu,Ling Kong,Fang Han,Su Zhao,Li Kong,Jun Yu |
|
| Lipids in Health and Disease. 2011; 10(1): 31 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 11 |
Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus: The Hidden Epidemic |
|
|
| Mona H. Ismail |
|
| The American Journal of the Medical Sciences. 2011; 341(6): 485 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 12 |
Correlative research between leptin and TGF-β1 and the recovery on CCl4 induced hepatic fibrosis in rats |
|
|
| Li, H. and Li, J. and Huang, C. and Huang, Y. and Zhang, L. and Li, Z.-T. and Zhang, S.-P. and Cheng, J. |
|
| Chinese Pharmacological Bulletin. 2011; 27(4): 473-477 |
|
| [Pubmed] [Google Scholar] |
|
| 13 |
Pharmacological therapy of nonalcoholic steatohepatitis |
|
|
| Mariko Hojo,Sumio Watanabe |
|
| Hepatology Research. 2011; 41(3): 209 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 14 |
Nonalcoholic fatty liver disease and type 2 diabetes mellitus: The hidden epidemic |
|
|
| Ismail, M.H. |
|
| American Journal of the Medical Sciences. 2011; 341(6): 485-492 |
|
| [Pubmed] [Google Scholar] |
|
| 15 |
Induction of heme oxygenase-1 protects against nutritional fibrosing steatohepatitis in mice |
|
|
| Wang, R.Q., Nan, Y.M., Wu, W.J., Kong, L.B., Han, F., Zhao, S.X., Kong, L., Yu, J. |
|
| Lipids in Health and Disease. 2011; 10(art 31) |
|
| [Pubmed] [Google Scholar] |
|
| 16 |
Advances in hepatic stellate cell-targeted treatment of hepatic fibrosis with bone marrow-derived mesenchymal stem cells |
|
|
| Hu, M.-D. and Guo, G.-H. |
|
| World Chinese Journal of Digestology. 2010; 18(24): 2558-2562 |
|
| [Pubmed] [Google Scholar] |
|
| 17 |
Liver fibrosis: A dynamic and potentially reversible process |
|
|
| Povero, D. and Busletta, C. and Novo, E. and Di Bonzo, L.V. and Cannito, S. and Paternostro, C. and Parola, M. |
|
| Histology and Histopathology. 2010; 25(8): 1075-1091 |
|
| [Pubmed] [Google Scholar] |
|
